Logo image of LGMK

LOGICMARK INC (LGMK) Stock Fundamental Analysis

NASDAQ:LGMK - Nasdaq - US67091J6029 - Common Stock

1.34  -0.07 (-4.96%)

Fundamental Rating

2

Taking everything into account, LGMK scores 2 out of 10 in our fundamental rating. LGMK was compared to 191 industry peers in the Health Care Equipment & Supplies industry. LGMK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. LGMK is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

LGMK had negative earnings in the past year.
LGMK had a negative operating cash flow in the past year.
In the past 5 years LGMK always reported negative net income.
LGMK had a negative operating cash flow in each of the past 5 years.
LGMK Yearly Net Income VS EBIT VS OCF VS FCFLGMK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5M -10M -15M

1.2 Ratios

LGMK's Return On Assets of -96.85% is on the low side compared to the rest of the industry. LGMK is outperformed by 82.11% of its industry peers.
With a Return On Equity value of -109.71%, LGMK is not doing good in the industry: 65.26% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -96.85%
ROE -109.71%
ROIC N/A
ROA(3y)-55.89%
ROA(5y)-45.83%
ROE(3y)-62.38%
ROE(5y)-72.24%
ROIC(3y)N/A
ROIC(5y)N/A
LGMK Yearly ROA, ROE, ROICLGMK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K

1.3 Margins

LGMK has a Gross Margin of 66.72%. This is in the better half of the industry: LGMK outperforms 72.11% of its industry peers.
LGMK's Gross Margin has been stable in the last couple of years.
LGMK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.72%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.19%
GM growth 5Y-1.39%
LGMK Yearly Profit, Operating, Gross MarginsLGMK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K -2K

More info and screens

6

2. Health

2.1 Basic Checks

LGMK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LGMK has been increased compared to 1 year ago.
Compared to 5 years ago, LGMK has more shares outstanding
There is no outstanding debt for LGMK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LGMK Yearly Shares OutstandingLGMK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M
LGMK Yearly Total Debt VS Total AssetsLGMK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -8.83, we must say that LGMK is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of LGMK (-8.83) is worse than 78.42% of its industry peers.
There is no outstanding debt for LGMK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -8.83
ROIC/WACCN/A
WACC9.25%
LGMK Yearly LT Debt VS Equity VS FCFLGMK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M

2.3 Liquidity

LGMK has a Current Ratio of 3.73. This indicates that LGMK is financially healthy and has no problem in meeting its short term obligations.
LGMK has a better Current ratio (3.73) than 68.42% of its industry peers.
A Quick Ratio of 3.29 indicates that LGMK has no problem at all paying its short term obligations.
LGMK's Quick ratio of 3.29 is fine compared to the rest of the industry. LGMK outperforms 70.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.73
Quick Ratio 3.29
LGMK Yearly Current Assets VS Current LiabilitesLGMK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M

More info and screens

0

3. Growth

3.1 Past

LGMK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -455.81%.
The Revenue has been growing slightly by 4.44% in the past year.
LGMK shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -10.32% yearly.
EPS 1Y (TTM)-455.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-354.55%
Revenue 1Y (TTM)4.44%
Revenue growth 3Y-4.62%
Revenue growth 5Y-10.32%
Sales Q2Q%14.15%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y98.68%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.03%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LGMK Yearly Revenue VS EstimatesLGMK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
LGMK Yearly EPS VS EstimatesLGMK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LGMK. In the last year negative earnings were reported.
Also next year LGMK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LGMK Price Earnings VS Forward Price EarningsLGMK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LGMK Per share dataLGMK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

LGMK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LOGICMARK INC

NASDAQ:LGMK (1/22/2025, 1:54:00 PM)

1.34

-0.07 (-4.96%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)N/A N/A
Inst Owners12.14%
Inst Owner Change0%
Ins Owners8%
Ins Owner Change75.31%
Market Cap2.43M
Analysts43.33
Price Target4.08 (204.48%)
Short Float %6.9%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.23
Dividend Growth(5Y)N/A
DP-1.93%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.22%
Min EPS beat(2)12.04%
Max EPS beat(2)54.4%
EPS beat(4)4
Avg EPS beat(4)18.43%
Min EPS beat(4)1.96%
Max EPS beat(4)54.4%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.64%
Min Revenue beat(2)-3.51%
Max Revenue beat(2)8.78%
Revenue beat(4)2
Avg Revenue beat(4)-0.06%
Min Revenue beat(4)-9.81%
Max Revenue beat(4)8.78%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)471.43%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-12.38%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.93%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.78%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.24
P/FCF N/A
P/OCF N/A
P/B 0.17
P/tB 0.45
EV/EBITDA N/A
EPS(TTM)-31.58
EYN/A
EPS(NY)-2.21
Fwd EYN/A
FCF(TTM)-2.22
FCFYN/A
OCF(TTM)-2.2
OCFYN/A
SpS5.57
BVpS7.82
TBVpS2.95
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -96.85%
ROE -109.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.72%
FCFM N/A
ROA(3y)-55.89%
ROA(5y)-45.83%
ROE(3y)-62.38%
ROE(5y)-72.24%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.19%
GM growth 5Y-1.39%
F-Score4
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.79%
Cap/Sales 0.25%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.73
Quick Ratio 3.29
Altman-Z -8.83
F-Score4
WACC9.25%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-455.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-354.55%
EPS Next Y98.68%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.44%
Revenue growth 3Y-4.62%
Revenue growth 5Y-10.32%
Sales Q2Q%14.15%
Revenue Next Year1.03%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y16.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.1%
OCF growth 3YN/A
OCF growth 5YN/A